Recurrence and occurrence of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment for chronic hepatitis C in patients with advanced liver disease: Turkish multi-center early access program

İdilman, RamazanDemir, MehmetAladağ, MuratKaymakoğlu, SabahattinErol, CihanÇavuş, Bilgerİliaz, RaimAkarca, Ulus S.Köklü, SeyfettinÇakaloğlu, YılmazŞahin, M.Köksal, I.Özgenel, MeriçToka, BilalKarasu, ZekiErsöz, GalipAkdoğan, Meral2023-11-202023-11-202018-04İdilman, R. vd. (2018). ''Recurrence and occurrence of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment for chronic hepatitis C in patients with advanced liver disease: Turkish multi-center early access program''. Journal of Hepatology, 68(Supplement1), S301-S301.0168-82781600-0641http://hdl.handle.net/11452/34946Bu çalışma, 11-15, Nisan 2018 tarihlerinde Paris[Fransa]’da düzenlenen International Liver Congress (ILC) Kongresi‘nde bildiri olarak sunulmuştur.eninfo:eu-repo/semantics/closedAccessGastroenterology & hepatologyRecurrence and occurrence of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment for chronic hepatitis C in patients with advanced liver disease: Turkish multi-center early access programMeeting Abstract000461068601213S301S30168Supplement 1Gastroenterology & hepatology